Text Size

Pharmacogenomic Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy in Korean Patients

This study is currently recruiting participants.
Verified September 2012 by Inje University
Sponsor:
Information provided by (Responsible Party):
Jae-Gook Shin, Inje University
ClinicalTrials.gov Identifier:
NCT01178502
First received: August 9, 2010
Last updated: September 20, 2012
Last verified: September 2012
History of Changes
  Purpose

This study aims to develop and validate the predictive warfarin dosing algorithm for personalized warfarin pharmacotherapy in Korean patients.


Condition
Heart Valves

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy in Korean Patients

Resource links provided by NLM:

MedlinePlus related topics: Blood Thinners
U.S. FDA Resources

Further study details as provided by Inje University:

Estimated Enrollment: 3000
Study Start Date: March 2008
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

the patients taking warfarin

Criteria

Inclusion Criteria:

  • the patients taking warfarin

Exclusion Criteria:

  • noncompliance
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01178502

Locations
Korea, Republic of
Inje University Recruiting
Busan, Korea, Republic of, 614-735
Contact: Jae Gook Shin, M.D., Ph.D.     82-51-890-6709     phshinjg@inje.ac.kr    
Sponsors and Collaborators
Inje University
  More Information

No publications provided

Responsible Party: Jae-Gook Shin, Department of Pharmacology and Pharmacogenomics Research Center, Inje University
ClinicalTrials.gov Identifier: NCT01178502     History of Changes
Other Study ID Numbers: 09-025
Study First Received: August 9, 2010
Last Updated: September 20, 2012
Health Authority: Korea: Institutional Review Board

Additional relevant MeSH terms:
Warfarin
Anticoagulants
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 23, 2013